Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Toll-Like Receptor 4-Dependent Activation of Dendritic Cells by -Defensin 2
Arya Biragyn,1*Pier Adelchi Ruffini,1Cynthia A. Leifer,2Elena Klyushnenkova,3Alexander Shakhov,3Oleg Chertov,4Aiko K. Shirakawa,5Joshua M. Farber,5David M. Segal,2Joost J. Oppenheim,6Larry W. Kwak1
-Defensins are small antimicrobial peptides of
the innate immune system produced in response to microbial infection of
mucosaltissue and skin. We demonstrate that murine -defensin 2 (mDF2)acts directly on immature dendritic cells as an endogenous
ligandfor Toll-like receptor 4 (TLR-4), inducing up-regulation
of costimulatorymolecules and dendritic cell maturation. These events,
in turn,trigger robust, type 1 polarized adaptive immune responses invivo, suggesting that mDF2 may play an important role in
immunosurveillanceagainst pathogens and, possibly, self antigens or
tumor antigens.
1 Experimental Transplantation and Immunology
Branch, National Cancer Institute, Bethesda, MD 20892, USA.
2 Experimental Immunology Branch, National Cancer
Institute, Bethesda, MD 20892-1360, USA.
3 Intramural Research Support Program and
4 Protein Chemistry Laboratory, Science Applications
International Corporation, Frederick, MD 21702, USA.
5 Laboratory of Clinical Investigation, National
Institute of Allergy and Infectious Diseases, National Institutes of
Health, Bethesda, MD 20892, USA.
6 Laboratory of
Molecular Immunoregulation, NCI, Frederick, MD 21702, USA.
*
To whom correspondence should be addressed. E-mail:
arya{at}mail.ncifcrf.gov
On leave of absence from Divisione di Oncologia Medica
Falck, Ospedale Niguarda Ca Granda, Milan, Italy.
Vaccine site inflammation potentiates idiotype DNA vaccine-induced therapeutic T cell-, and not B cell-, dependent antilymphoma immunity.
H. Qin, S.-c. Cha, S. S. Neelapu, Y. Lou, J. Wei, Y.-J. Liu, and L. W. Kwak (2009)
Blood
114, 4142-4149
|Abstract »|Full Text »|PDF »
Endotoxin tolerance dysregulates MyD88- and Toll/IL-1R domain-containing adapter inducing IFN-{beta}-dependent pathways and increases expression of negative regulators of TLR signaling.
W. Piao, C. Song, H. Chen, M. A. Quevedo Diaz, L. M. Wahl, K. A. Fitzgerald, L. Li, and A. E. Medvedev (2009)
J. Leukoc. Biol.
86, 863-875
|Abstract »|Full Text »|PDF »
Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease.
Involvement of TLR2 and TLR4 in inflammatory immune responses induced by fine and coarse ambient air particulate matter.
J. Shoenfelt, R. J. Mitkus, R. Zeisler, R. O. Spatz, J. Powell, M. J. Fenton, K. A. Squibb, and A. E. Medvedev (2009)
J. Leukoc. Biol.
86, 303-312
|Abstract »|Full Text »|PDF »
Emerging role of Toll-like receptors in atherosclerosis.
Stimulation of Specific Cytokines in Human Conjunctival Epithelial Cells by Defensins HNP1, HBD2, and HBD3.
J. Li, H. Y. Zhu, and R. W. Beuerman (2009)
Invest. Ophthalmol. Vis. Sci.
50, 644-653
|Abstract »|Full Text »|PDF »
{beta}-Defensin-2 Promotes Resistance against Infection with P. aeruginosa.
M. Wu, S. A. McClellan, R. P. Barrett, and L. D. Hazlett (2009)
J. Immunol.
182, 1609-1616
|Abstract »|Full Text »|PDF »
Human {alpha}-Defensins Inhibit BK Virus Infection by Aggregating Virions and Blocking Binding to Host Cells.
A. S. Dugan, M. S. Maginnis, J. A. Jordan, M. L. Gasparovic, K. Manley, R. Page, G. Williams, E. Porter, B. A. O'Hara, and W. J. Atwood (2008)
J. Biol. Chem.
283, 31125-31132
|Abstract »|Full Text »|PDF »
Defensins and the dynamic genome: What we can learn from structural variation at human chromosome band 8p23.1.
E. J. Hollox, J. C.K. Barber, A. J. Brookes, and J. A.L. Armour (2008)
Genome Res.
18, 1686-1697
|Abstract »|Full Text »|PDF »
The Relative Efficiency of Acquisition of MHC:Peptide Complexes and Cross-Presentation Depends on Dendritic Cell Type.
L. A. Smyth, N. Harker, W. Turnbull, H. El-Doueik, L. Klavinskis, D. Kioussis, G. Lombardi, and R. Lechler (2008)
J. Immunol.
181, 3212-3220
|Abstract »|Full Text »|PDF »
Lactoferrin, a major defense protein of innate immunity, is a novel maturation factor for human dendritic cells.
M. Spadaro, C. Caorsi, P. Ceruti, A. Varadhachary, G. Forni, F. Pericle, and M. Giovarelli (2008)
FASEB J
22, 2747-2757
|Abstract »|Full Text »|PDF »
Is serum amyloid A an endogenous TLR4 agonist?.
S. Sandri, D. Rodriguez, E. Gomes, H. P. Monteiro, M. Russo, and A. Campa (2008)
J. Leukoc. Biol.
83, 1174-1180
|Abstract »|Full Text »|PDF »
Drosomycin-Like Defensin, a Human Homologue of Drosophila melanogaster Drosomycin with Antifungal Activity.
A. Simon, B. J. Kullberg, B. Tripet, O. C. Boerman, P. Zeeuwen, J. van der Ven-Jongekrijg, P. Verweij, J. Schalkwijk, R. Hodges, J. W. M. van der Meer, et al. (2008)
Antimicrob. Agents Chemother.
52, 1407-1412
|Abstract »|Full Text »|PDF »
Murine {beta}-defensin 2 promotes TLR-4/MyD88-mediated and NF-{kappa}B-dependent atypical death of APCs via activation of TNFR2.
A. Biragyn, M. Coscia, K. Nagashima, M. Sanford, H. A. Young, and P. Olkhanud (2008)
J. Leukoc. Biol.
83, 998-1008
|Abstract »|Full Text »|PDF »
A Vicious Cycle Involving Release of Heat Shock Protein 60 from Injured Cells and Activation of Toll-Like Receptor 4 Mediates Neurodegeneration in the CNS.
S. Lehnardt, E. Schott, T. Trimbuch, D. Laubisch, C. Krueger, G. Wulczyn, R. Nitsch, and J. R. Weber (2008)
J. Neurosci.
28, 2320-2331
|Abstract »|Full Text »|PDF »
Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2-MyD88 signal pathway in dendritic cells and enhances Th2 immune responses.
D. Yang, Q. Chen, S. B. Su, P. Zhang, K. Kurosaka, R. R. Caspi, S. M. Michalek, H. F. Rosenberg, N. Zhang, and J. J. Oppenheim (2008)
J. Exp. Med.
205, 79-90
|Abstract »|Full Text »|PDF »
A -Defensin Mutation Causes Black Coat Color in Domestic Dogs.
S. I. Candille, C. B. Kaelin, B. M. Cattanach, B. Yu, D. A. Thompson, M. A. Nix, J. A. Kerns, S. M. Schmutz, G. L. Millhauser, and G. S. Barsh (2007)
Science
318, 1418-1423
|Abstract »|Full Text »|PDF »
Human -defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2.
N. Funderburg, M. M. Lederman, Z. Feng, M. G. Drage, J. Jadlowsky, C. V. Harding, A. Weinberg, and S. F. Sieg (2007)
PNAS
104, 18631-18635
|Abstract »|Full Text »|PDF »
Immunity against Tumor Angiogenesis Induced by a Fusion Vaccine with Murine {beta}-Defensin 2 and mFlk-1.
Y.-s. Wang, G.-q. Wang, Y.-j. Wen, L. Wang, X.-c. Chen, P. Chen, B. Kan, J. Li, C. Huang, Y. Lu, et al. (2007)
Clin. Cancer Res.
13, 6779-6787
|Abstract »|Full Text »|PDF »
Human immature monocyte-derived dendritic cells produce and secrete {alpha}-defensins 1 3.
M. Rodriguez-Garcia, H. Oliva, N. Climent, F. Garcia, J. M. Gatell, and T. Gallart (2007)
J. Leukoc. Biol.
82, 1143-1146
|Abstract »|Full Text »|PDF »
Innate Recognition Network Driving Herpes Simplex Virus-Induced Corneal Immunopathology: Role of the Toll Pathway in Early Inflammatory Events in Stromal Keratitis.
P. P. Sarangi, B. Kim, E. Kurt-Jones, and B. T. Rouse (2007)
J. Virol.
81, 11128-11138
|Abstract »|Full Text »|PDF »
Protease-Activated Receptor 2 Mediates Human Beta-Defensin 2 and CC Chemokine Ligand 20 mRNA Expression in Response to Proteases Secreted by Porphyromonas gingivalis.
H. Dommisch, W. O. Chung, M. G. Rohani, D. Williams, M. Rangarajan, M. A. Curtis, and B. A. Dale (2007)
Infect. Immun.
75, 4326-4333
|Abstract »|Full Text »|PDF »
Regulation of TLR4 signaling and the host interface with pathogens and danger: the role of RP105.
S. Divanovic, A. Trompette, L. K. Petiniot, J. L. Allen, L. M. Flick, Y. Belkaid, R. Madan, J. J. Haky, and C. L. Karp (2007)
J. Leukoc. Biol.
82, 265-271
|Abstract »|Full Text »|PDF »
Tumor-Associated Embryonic Antigen-Expressing Vaccines that Target CCR6 Elicit Potent CD8+ T Cell-Mediated Protective and Therapeutic Antitumor Immunity.
A. Biragyn, R. Schiavo, P. Olkhanud, K. Sumitomo, A. King, M. McCain, F. E. Indig, G. Almanzar, and D. Baatar (2007)
J. Immunol.
179, 1381-1388
|Abstract »|Full Text »|PDF »
Characterization of Heme as Activator of Toll-like Receptor 4.
R. T. Figueiredo, P. L. Fernandez, D. S. Mourao-Sa, B. N. Porto, F. F. Dutra, L. S. Alves, M. F. Oliveira, P. L. Oliveira, A. V. Graca-Souza, and M. T. Bozza (2007)
J. Biol. Chem.
282, 20221-20229
|Abstract »|Full Text »|PDF »
Invited review: NOD2 and defensins: translating innate to adaptive immunity in Crohn's disease.
L. Peyrin-Biroulet and M. Chamaillard (2007)
Innate Immunity
13, 135-139
|Abstract »|PDF »
beta-Defensin overexpression induces progressive muscle degeneration in mice.
Y. Yamaguchi, T. Nagase, T. Tomita, K. Nakamura, S. Fukuhara, T. Amano, H. Yamamoto, Y. Ide, M. Suzuki, S. Teramoto, et al. (2007)
Am J Physiol Cell Physiol
292, C2141-C2149
|Abstract »|Full Text »|PDF »
Molecular and Cellular Basis of Microflora-Host Interactions.
P. Winkler, D. Ghadimi, J. Schrezenmeir, and J.-P. Kraehenbuhl (2007)
J. Nutr.
137, 756S-772S
|Abstract »|Full Text »|PDF »
Review: Pathogen-associated molecular pattern contamination as putative endogenous ligands of Toll-like receptors.
Uncovering host defences in the urinary tract: cathelicidin and beyond.
M. D. Saemann, W. H. Horl, and T. Weichhart (2007)
Nephrol. Dial. Transplant.
22, 347-349
|Full Text »|PDF »
Induction of the Antimicrobial Peptide CRAMP in the Blood-Brain Barrier and Meninges after Meningococcal Infection.
P. Bergman, L. Johansson, H. Wan, A. Jones, R. L. Gallo, G. H. Gudmundsson, T. Hokfelt, A.-B. Jonsson, and B. Agerberth (2006)
Infect. Immun.
74, 6982-6991
|Abstract »|Full Text »|PDF »
Immunostimulatory combinations: designing the next generation of vaccine adjuvants.
Defensins HNP1 and HBD2 Stimulation of Wound-Associated Responses in Human Conjunctival Fibroblasts..
J. Li, M. Raghunath, D. Tan, R. R. Lareu, Z. Chen, and R. W. Beuerman (2006)
Invest. Ophthalmol. Vis. Sci.
47, 3811-3819
|Abstract »|Full Text »|PDF »
Toxoplasma gondii Genotype Determines MyD88-Dependent Signaling in Infected Macrophages.
L. Kim, B. A. Butcher, C. W. Lee, S. Uematsu, S. Akira, and E. Y. Denkers (2006)
J. Immunol.
177, 2584-2591
|Abstract »|Full Text »|PDF »
Cutting Edge: Human beta Defensin 3--A Novel Antagonist of the HIV-1 Coreceptor CXCR4.
Z. Feng, G. R. Dubyak, M. M. Lederman, and A. Weinberg (2006)
J. Immunol.
177, 782-786
|Abstract »|Full Text »|PDF »
Hyaluronan Fragments Act as an Endogenous Danger Signal by Engaging TLR2.
K. A. Scheibner, M. A. Lutz, S. Boodoo, M. J. Fenton, J. D. Powell, and M. R. Horton (2006)
J. Immunol.
177, 1272-1281
|Abstract »|Full Text »|PDF »
The 3' CCACCA Sequence of tRNAAla(UGC) Is the Motif That Is Important in Inducing Th1-Like Immune Response, and This Motif Can Be Recognized by Toll-Like Receptor 3..
Z. Wang, L. Xiang, J. Shao, and Z. Yuan (2006)
Clin. Vaccine Immunol.
13, 733-739
|Abstract »|Full Text »|PDF »
Toll-Like Receptors: The Interface between Innate and Adaptive Immunity.
P. G. Tipping (2006)
J. Am. Soc. Nephrol.
17, 1769-1771
|Full Text »|PDF »
Chemokine receptor targeting efficiently directs antigens to MHC class I pathways and elicits antigen-specific CD8+ T-cell responses.
R. Schiavo, D. Baatar, P. Olkhanud, F. E. Indig, N. Restifo, D. Taub, and A. Biragyn (2006)
Blood
107, 4597-4605
|Abstract »|Full Text »|PDF »
The Antimicrobial/Elastase Inhibitor Elafin Regulates Lung Dendritic Cells and Adaptive Immunity.
A. Roghanian, S. E. Williams, T. A. Sheldrake, T. I. Brown, K. Oberheim, Z. Xing, S. E. M. Howie, and J.-M. Sallenave (2006)
Am. J. Respir. Cell Mol. Biol.
34, 634-642
|Abstract »|Full Text »|PDF »
Impaired maturation and altered regulatory function of plasmacytoid dendritic cells in multiple sclerosis.
M. Stasiolek, A. Bayas, N. Kruse, A. Wieczarkowiecz, K. V. Toyka, R. Gold, and K. Selmaj (2006)
Brain
129, 1293-1305
|Abstract »|Full Text »|PDF »
Human {beta}-Defensin 2 Induces a Vigorous Cytokine Response in Peripheral Blood Mononuclear Cells..
M. Boniotto, W. J. Jordan, J. Eskdale, A. Tossi, N. Antcheva, S. Crovella, N. D. Connell, and G. Gallagher (2006)
Antimicrob. Agents Chemother.
50, 1433-1441
|Abstract »|Full Text »|PDF »
Role of Human {beta}-defensins in HIV Infection.
A. Weinberg, M.E. Quinones-Mateu, and M.M. Lederman (2006)
Advances in Dental Research
19, 42-48
|Abstract »|Full Text »|PDF »
(C3) The Oral Epithelial Cell and First Encounters with HIV-1.
M.C. Herzberg, A. Weinberg, and S.M. Wahl (2006)
Advances in Dental Research
19, 158-166
|Abstract »|Full Text »|PDF »
Expression of CRAMP via PGN-TLR-2 and of {alpha}-defensin-3 via CpG-ODN-TLR-9 in corneal fibroblasts..
S Rodriguez-Martinez, M E Cancino-Diaz, and J C Cancino-Diaz (2006)
Br J Ophthalmol
90, 378-382
|Abstract »|Full Text »|PDF »
Vaccine with {beta}-Defensin 2-Transduced Leukemic Cells Activates Innate and Adaptive Immunity to Elicit Potent Antileukemia Responses.
X.-T. Ma, B. Xu, L.-L. An, C.-Y. Dong, Y.-M. Lin, Y. Shi, and K.-F. Wu (2006)
Cancer Res.
66, 1169-1176
|Abstract »|Full Text »|PDF »
Abrupt Expression of TLR4 in TLR4-Deficient Macrophages Imposes a Selective Disadvantage: Genetic Evidence for TLR4-Dependent Responses to Endogenous, Nonmicrobial Stimuli.
E. F. Cohn, C. Nathan, D. Radzioch, H. Yu, Z. Xiang, and A. Ding (2006)
J. Immunol.
176, 1185-1194
|Abstract »|Full Text »|PDF »
Why Is the Arg5-Glu13 Salt Bridge Conserved in Mammalian {alpha}-Defensins?.
Z. Wu, X. Li, E. de Leeuw, B. Ericksen, and W. Lu (2005)
J. Biol. Chem.
280, 43039-43047
|Abstract »|Full Text »|PDF »
Human {beta}-Defensins Suppress Human Immunodeficiency Virus Infection: Potential Role in Mucosal Protection.
L. Sun, C. M. Finnegan, T. Kish-Catalone, R. Blumenthal, P. Garzino-Demo, G. M. La Terra Maggiore, S. Berrone, C. Kleinman, Z. Wu, S. Abdelwahab, et al. (2005)
J. Virol.
79, 14318-14329
|Abstract »|Full Text »|PDF »
Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus.
F. J. Barrat, T. Meeker, J. Gregorio, J. H. Chan, S. Uematsu, S. Akira, B. Chang, O. Duramad, and R. L. Coffman (2005)
J. Exp. Med.
202, 1131-1139
|Abstract »|Full Text »|PDF »
Reconstruction of the Conserved {beta}-Bulge in Mammalian Defensins Using D-Amino Acids.
C. Xie, A. Prahl, B. Ericksen, Z. Wu, P. Zeng, X. Li, W.-Y. Lu, J. Lubkowski, and W. Lu (2005)
J. Biol. Chem.
280, 32921-32929
|Abstract »|Full Text »|PDF »
Pulmonary Dendritic Cells.
K. Vermaelen and R. Pauwels (2005)
Am. J. Respir. Crit. Care Med.
172, 530-551
|Abstract »|Full Text »|PDF »
Cationic Antimicrobial Peptide Resistance in Neisseria meningitidis.
Y.-L. Tzeng, K. D. Ambrose, S. Zughaier, X. Zhou, Y. K. Miller, W. M. Shafer, and D. S. Stephens (2005)
J. Bacteriol.
187, 5387-5396
|Abstract »|Full Text »|PDF »
BACTERIAL INTERACTIONS WITH CELLS OF THE INTESTINAL MUCOSA: TOLL-LIKE RECEPTORS AND NOD2.
Toll-Like Receptors on Tumor Cells Facilitate Evasion of Immune Surveillance.
B. Huang, J. Zhao, H. Li, K.-L. He, Y. Chen, L. Mayer, J. C. Unkeless, and H. Xiong (2005)
Cancer Res.
65, 5009-5014
|Abstract »|Full Text »|PDF »
Impact of LL-37 on anti-infective immunity.
D. M. E. Bowdish, D. J. Davidson, Y. E. Lau, K. Lee, M. G. Scott, and R. E. W. Hancock (2005)
J. Leukoc. Biol.
77, 451-459
|Abstract »|Full Text »|PDF »
Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease.
J. Wehkamp, M. Schmid, K. Fellermann, and E. F. Stange (2005)
J. Leukoc. Biol.
77, 460-465
|Abstract »|Full Text »|PDF »
Thematic review series: The Immune System and Atherogenesis. Paying the price for pathogen protection: toll receptors in atherogenesis.
Human Ribonuclease A Superfamily Members, Eosinophil-Derived Neurotoxin and Pancreatic Ribonuclease, Induce Dendritic Cell Maturation and Activation.
D. Yang, Q. Chen, H. F. Rosenberg, S. M. Rybak, D. L. Newton, Z. Y. Wang, Q. Fu, V. T. Tchernev, M. Wang, B. Schweitzer, et al. (2004)
J. Immunol.
173, 6134-6142
|Abstract »|Full Text »|PDF »
Antimicrobial proteins and peptides: anti-infective molecules of mammalian leukocytes.
{beta}-Defensin-2 Expression Is Regulated by TLR Signaling in Intestinal Epithelial Cells.
P. Vora, A. Youdim, L. S. Thomas, M. Fukata, S. Y. Tesfay, K. Lukasek, K. S. Michelsen, A. Wada, T. Hirayama, M. Arditi, et al. (2004)
J. Immunol.
173, 5398-5405
|Abstract »|Full Text »|PDF »
Highly Tissue Substructure-Specific Effects of Human Papilloma Virus in Mucosa of HIV-Infected Patients Revealed by Laser-Dissection Microscopy-Assisted Gene Expression Profiling.
N. Baumgarth, R. Szubin, G. M. Dolganov, M. R. Watnik, D. Greenspan, M. Da Costa, J. M. Palefsky, R. Jordan, M. Roederer, and J. S. Greenspan (2004)
Am. J. Pathol.
165, 707-718
|Abstract »|Full Text »|PDF »
Temporin A and Related Frog Antimicrobial Peptides Use Formyl Peptide Receptor-Like 1 as a Receptor to Chemoattract Phagocytes.
Q. Chen, D. Wade, K. Kurosaka, Z. Y. Wang, J. J. Oppenheim, and D. Yang (2004)
J. Immunol.
173, 2652-2659
|Abstract »|Full Text »|PDF »
Enhanced Surfactant Protein and Defensin mRNA Levels and Reduced Viral Replication during Parainfluenza Virus Type 3 Pneumonia in Neonatal Lambs.
B. Grubor, J. M. Gallup, D. K. Meyerholz, E. C. Crouch, R. B. Evans, K. A. Brogden, H. D. Lehmkuhl, and M. R. Ackermann (2004)
Clin. Vaccine Immunol.
11, 599-607
|Abstract »|Full Text »|PDF »
Toll-like receptors: function and roles in lung disease.
S. Basu and M. J. Fenton (2004)
Am J Physiol Lung Cell Mol Physiol
286, L887-L892
|Abstract »|Full Text »|PDF »
Signaling Danger: Toll-Like Receptors and their Potential Roles in Kidney Disease.
H.-J. Anders, B. Banas, and D. Schlondorff (2004)
J. Am. Soc. Nephrol.
15, 854-867
|Abstract »|Full Text »|PDF »
Human Rhinovirus Infection Induces Airway Epithelial Cell Production of Human {beta}-Defensin 2 Both In Vitro and In Vivo.
Gangliosides Act as Co-receptors for Salmonella enteritidis FliC and Promote FliC Induction of Human {beta}-Defensin-2 Expression in Caco-2 Cells.
K.-i. Ogushi, A. Wada, T. Niidome, T. Okuda, R. Llanes, M. Nakayama, Y. Nishi, H. Kurazono, K. D. Smith, A. Aderem, et al. (2004)
J. Biol. Chem.
279, 12213-12219
|Abstract »|Full Text »|PDF »
Identification on Mouse Chromosome 8 of New {beta}-Defensin Genes with Regionally Specific Expression in the Male Reproductive Organ.
A. Zaballos, R. Villares, J. P. Albar, C. Martinez-A, and G. Marquez (2004)
J. Biol. Chem.
279, 12421-12426
|Abstract »|Full Text »|PDF »
mRNA Is an Endogenous Ligand for Toll-like Receptor 3.
K. Kariko, H. Ni, J. Capodici, M. Lamphier, and D. Weissman (2004)
J. Biol. Chem.
279, 12542-12550
|Abstract »|Full Text »|PDF »
A Role for Toll-Like Receptor 4 in Dendritic Cell Activation and Cytolytic CD8+ T Cell Differentiation in Response to a Recombinant Heat Shock Fusion Protein.
D. Palliser, Q. Huang, N. Hacohen, S. P. Lamontagne, E. Guillen, R. A. Young, and H. N. Eisen (2004)
J. Immunol.
172, 2885-2893
|Abstract »|Full Text »|PDF »
Innate immunity in the lung: how epithelial cells fight against respiratory pathogens.
Neutrophil Defensins Enhance Lung Epithelial Wound Closure and Mucin Gene Expression In Vitro.
J. Aarbiou, R. M. Verhoosel, S. van Wetering, W. I. de Boer, J. H. J. M. van Krieken, S. V. Litvinov, K. F. Rabe, and P. S. Hiemstra (2004)
Am. J. Respir. Cell Mol. Biol.
30, 193-201
|Abstract »|Full Text »|PDF »
The Cationic Antimicrobial Peptide LL-37 Modulates Dendritic Cell Differentiation and Dendritic Cell-Induced T Cell Polarization.
D. J. Davidson, A. J. Currie, G. S. D. Reid, D. M. E. Bowdish, K. L. MacDonald, R. C. Ma, R. E. W. Hancock, and D. P. Speert (2004)
J. Immunol.
172, 1146-1156
|Abstract »|Full Text »|PDF »
Biology of Toll receptors: lessons from insects and mammals.
Activation of Toll-Like Receptor 2 on Human Tracheobronchial Epithelial Cells Induces the Antimicrobial Peptide Human {beta} Defensin-2.
C. J. Hertz, Q. Wu, E. M. Porter, Y. J. Zhang, K.-H. Weismuller, P. J. Godowski, T. Ganz, S. H. Randell, and R. L. Modlin (2003)
J. Immunol.
171, 6820-6826
|Abstract »|Full Text »|PDF »
Immunodeficiency virus exploitation of dendritic cells in the early steps of infection.
Roles of antimicrobial peptides such as defensins in innate and adaptive immunity.
J J Oppenheim, A Biragyn, L W Kwak, and D Yang (2003)
Ann Rheum Dis
62, ii17-21
|Abstract »|Full Text »|PDF »
MyD88 Primes Macrophages for Full-Scale Activation by Interferon-{gamma} yet Mediates Few Responses to Mycobacterium tuberculosis.
S. Shi, C. Nathan, D. Schnappinger, J. Drenkow, M. Fuortes, E. Block, A. Ding, T. R. Gingeras, G. Schoolnik, S. Akira, et al. (2003)
J. Exp. Med.
198, 987-997
|Abstract »|Full Text »|PDF »
CCL9 Is Secreted by the Follicle-Associated Epithelium and Recruits Dome Region Peyer's Patch CD11b+ Dendritic Cells.
X. Zhao, A. Sato, C. S. Dela Cruz, M. Linehan, A. Luegering, T. Kucharzik, A.-K. Shirakawa, G. Marquez, J. M. Farber, I. Williams, et al. (2003)
J. Immunol.
171, 2797-2803
|Abstract »|Full Text »|PDF »
Haplotype variation in bovine Toll-like receptor 4 and computational prediction of a positively selected ligand-binding domain.
S. N. White, K. H. Taylor, C. A. Abbey, C. A. Gill, and J. E. Womack (2003)
PNAS
100, 10364-10369
|Abstract »|Full Text »|PDF »
Expression of Human {beta}-Defensins in Conjunctival Epithelium: Relevance to Dry Eye Disease.
S. Narayanan, W. L. Miller, and A. M. McDermott (2003)
Invest. Ophthalmol. Vis. Sci.
44, 3795-3801
|Abstract »|Full Text »|PDF »
Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: Activation of Toll-like receptor 7.
J. Lee, T.-H. Chuang, V. Redecke, L. She, P. M. Pitha, D. A. Carson, E. Raz, and H. B. Cottam (2003)
PNAS
100, 6646-6651
|Abstract »|Full Text »|PDF »